Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis

Liver fibrosis is the excessive extracellular matrix accumulation of proteins, such as collagen, which follows the chronic liver diseases. Advanced liver fibrosis leads to cirrhosis and liver failure. Nilotinib is a second-generation tyrosine kinase inhibitor, which showed antifibrotic efficacy. Ste...

Full description

Saved in:
Bibliographic Details
Main Authors: Gamal Shiha, Ahmed Nabil, Ahmed Lotfy, Reham Soliman, Ayman A. Hassan, Islam S. Ali, Doaa F. Gad, Faten Zahran
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2020/6574010
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560167207567360
author Gamal Shiha
Ahmed Nabil
Ahmed Lotfy
Reham Soliman
Ayman A. Hassan
Islam S. Ali
Doaa F. Gad
Faten Zahran
author_facet Gamal Shiha
Ahmed Nabil
Ahmed Lotfy
Reham Soliman
Ayman A. Hassan
Islam S. Ali
Doaa F. Gad
Faten Zahran
author_sort Gamal Shiha
collection DOAJ
description Liver fibrosis is the excessive extracellular matrix accumulation of proteins, such as collagen, which follows the chronic liver diseases. Advanced liver fibrosis leads to cirrhosis and liver failure. Nilotinib is a second-generation tyrosine kinase inhibitor, which showed antifibrotic efficacy. Stem cell therapy still has some limitations such as oncogenesis, unexpected differentiation, and ethical consideration. Stem cells secrete cytokines and growth factors that showed paracrine-mediated antifibrotic and anti-inflammatory effects in vivo and in vitro. Thus, stem cell-conditioned medium (SC-CM), which contains the secretory proteins of stem cells, may have an antifibrotic role. This study was carried out to examine the antifibrotic effect of Nilotinib and stem cell exosomes on CCl4-induced liver fibrosis in rats. Male Wistar rats were injected intraperitoneally with CCl4 twice a week for 9 weeks and given daily treatments of Nilotinib (20 mg/kg), stem cell exosomes (0.5 ml/rat), and the combination treatment of Nilotinib and stem cell exosomes during the last 5 weeks of CCl4 intoxication. Liver fibrosis and also antifibrotic efficacy of the treatments were estimated with liver function tests, oxidative stress parameters, apoptotic parameters, histopathological examination, and hydroxyproline contents. Results showed that the combination of Nilotinib and stem cell-conditioned media had more antifibrotic effects than each one alone (P value < 0.001).
format Article
id doaj-art-2726971ed3094f2bbcfddbe9dde9bc37
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-2726971ed3094f2bbcfddbe9dde9bc372025-02-03T01:28:16ZengWileyStem Cells International1687-966X1687-96782020-01-01202010.1155/2020/65740106574010Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver FibrosisGamal Shiha0Ahmed Nabil1Ahmed Lotfy2Reham Soliman3Ayman A. Hassan4Islam S. Ali5Doaa F. Gad6Faten Zahran7Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, EgyptEgyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, EgyptEgyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, EgyptEgyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, EgyptEgyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, EgyptDelta University for Science and Technology, EgyptHepatology and Gastroenterology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, EgyptBiochemistry Department, Faculty of Science, Zagazig University, EgyptLiver fibrosis is the excessive extracellular matrix accumulation of proteins, such as collagen, which follows the chronic liver diseases. Advanced liver fibrosis leads to cirrhosis and liver failure. Nilotinib is a second-generation tyrosine kinase inhibitor, which showed antifibrotic efficacy. Stem cell therapy still has some limitations such as oncogenesis, unexpected differentiation, and ethical consideration. Stem cells secrete cytokines and growth factors that showed paracrine-mediated antifibrotic and anti-inflammatory effects in vivo and in vitro. Thus, stem cell-conditioned medium (SC-CM), which contains the secretory proteins of stem cells, may have an antifibrotic role. This study was carried out to examine the antifibrotic effect of Nilotinib and stem cell exosomes on CCl4-induced liver fibrosis in rats. Male Wistar rats were injected intraperitoneally with CCl4 twice a week for 9 weeks and given daily treatments of Nilotinib (20 mg/kg), stem cell exosomes (0.5 ml/rat), and the combination treatment of Nilotinib and stem cell exosomes during the last 5 weeks of CCl4 intoxication. Liver fibrosis and also antifibrotic efficacy of the treatments were estimated with liver function tests, oxidative stress parameters, apoptotic parameters, histopathological examination, and hydroxyproline contents. Results showed that the combination of Nilotinib and stem cell-conditioned media had more antifibrotic effects than each one alone (P value < 0.001).http://dx.doi.org/10.1155/2020/6574010
spellingShingle Gamal Shiha
Ahmed Nabil
Ahmed Lotfy
Reham Soliman
Ayman A. Hassan
Islam S. Ali
Doaa F. Gad
Faten Zahran
Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
Stem Cells International
title Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
title_full Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
title_fullStr Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
title_full_unstemmed Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
title_short Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis
title_sort antifibrotic effect of combination of nilotinib and stem cell conditioned media on ccl4 induced liver fibrosis
url http://dx.doi.org/10.1155/2020/6574010
work_keys_str_mv AT gamalshiha antifibroticeffectofcombinationofnilotinibandstemcellconditionedmediaonccl4inducedliverfibrosis
AT ahmednabil antifibroticeffectofcombinationofnilotinibandstemcellconditionedmediaonccl4inducedliverfibrosis
AT ahmedlotfy antifibroticeffectofcombinationofnilotinibandstemcellconditionedmediaonccl4inducedliverfibrosis
AT rehamsoliman antifibroticeffectofcombinationofnilotinibandstemcellconditionedmediaonccl4inducedliverfibrosis
AT aymanahassan antifibroticeffectofcombinationofnilotinibandstemcellconditionedmediaonccl4inducedliverfibrosis
AT islamsali antifibroticeffectofcombinationofnilotinibandstemcellconditionedmediaonccl4inducedliverfibrosis
AT doaafgad antifibroticeffectofcombinationofnilotinibandstemcellconditionedmediaonccl4inducedliverfibrosis
AT fatenzahran antifibroticeffectofcombinationofnilotinibandstemcellconditionedmediaonccl4inducedliverfibrosis